Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.
about
Steroid hormones, steroid receptors, and breast cancer stem cellsKeratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance.Minireview: prolactin regulation of adult stem cellsB-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cellsBCL6 is a negative prognostic factor and exhibits pro-oncogenic activity in ovarian cancer.Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.Prolactin Inhibits BCL6 Expression in Breast Cancer Cells through a MicroRNA-339-5p-Dependent PathwayGlobal profiling of prolactin-modulated transcripts in breast cancer in vivo.Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.The Role of Steroid Hormones in Breast and Effects on Cancer Stem Cells.Breast carcinoma associated with prolactinoma: A case report.
P2860
Q26799113-5A40B266-ED49-4DF3-BB4D-FE885A88A24EQ33566693-9A98125B-7C14-4F02-BA3A-95A7B413BD96Q33631708-4541BD8D-84E2-42F6-AA3B-D01331DF9D9BQ33786387-485A5E26-5E05-467D-8830-B681197EAE3EQ34991219-9B19A4D3-9E46-47F8-9EA9-56098949970FQ35205643-938B98D0-970F-4639-96C1-E4B841604208Q36707715-22ECB74E-EE1C-4A30-8AE0-1E7D64818DB1Q36768980-4B78CCEA-326C-404A-897B-EFD8E0348E4CQ36952878-D2342753-4304-4EAF-A72C-AC60C349C50EQ37306543-84793BF8-1598-4E86-98E3-98D3E9059451Q37689956-6350F736-E1B1-4544-BA48-13659492A9AAQ38373935-FEE17F36-C93C-49C8-8511-03AFA6B03CD2Q38923425-3CAC106F-56EE-4CFE-B5E2-B8698822383BQ47101494-16E3EA53-3459-4A86-ACFD-F8DE3296E867Q52620231-F0CB00AB-C1B2-487A-94BF-626A788979C8Q54319907-FD376F11-346C-4CF0-A909-A70589562D8B
P2860
Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prolactin suppresses a progest ...... gestin-driven BCL6 expression.
@en
Prolactin suppresses a progest ...... gestin-driven BCL6 expression.
@nl
type
label
Prolactin suppresses a progest ...... gestin-driven BCL6 expression.
@en
Prolactin suppresses a progest ...... gestin-driven BCL6 expression.
@nl
prefLabel
Prolactin suppresses a progest ...... gestin-driven BCL6 expression.
@en
Prolactin suppresses a progest ...... gestin-driven BCL6 expression.
@nl
P2093
P2860
P356
P1433
P1476
Prolactin suppresses a progest ...... gestin-driven BCL6 expression.
@en
P2093
A J Kovatich
C D Shriver
C R Goodman
I Chervoneva
L M Neilson
P2860
P2888
P304
P356
10.1038/ONC.2013.172
P407
P577
2013-05-27T00:00:00Z